BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell) for human use (rHSV2hGM-CSF).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.